Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma

Melanoma Research

Volumn 6, Issue 1, 1996, Pages 31-35

  Danen, E H J ^c   Ten Berge, P J M ^a   Van Muijen, G N P ^c   Jager, M J ^b   Ruiter, D J ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adhesion molecule; CD44; Hyaluronate receptor; Splice variants; Uveal melanoma

Indexed keywords

HERMES ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; UVEA MELANOMA;

ALTERNATIVE SPLICING; ANTIGENS, CD44; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0030062163     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199602000-00005     Document Type: Article

References (25)

1. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
2. Arrufo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-1313.
3. Thomas L, Byers RH, Vink J, Stamenkovic I. CD44H regulates tumour cell migration on hyaluronate-coated substrate. J Cell Biol 1992; 118: 971-977.
4. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343-348.
5. He Q, Lesley J, Hyman R, Ishihara K, Kincade PW. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 1992; 119: 1711-1719.
6. Koopman G, Heider K-H, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
7. Heider K-H, Hofmann M, Horst E, et al. A human homologue of rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-233.
8. Wielenga VJM, Heider K-H, Offerhaus GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumour progression. Cancer Res 1993; 53: 4754-4756.
9. Heider K-H, Dammrich J, Skroch-Angel P, et al. Differential expression of CD44 splice variants in intestinal and diffuse type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993; 53: 4197-4203.
10. Dall P, Heider K-H, Hekele S, et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical and normal epithelium. Cancer Res 1994; 54: 3337-3341.
11. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
12. Seiter S, Arch R, Reber S, et al. Prevention of tumour metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443-455.
13. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumour development. J Exp Med 1994; 180: 53-66.
14. Guo Y, Ma J, Wang J, et al. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 1994; 54: 1561-1565.
15. East JA, Mitchell SD, Hart IR. Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res 1993; 3: 341-346.
16. Van Muijen GNP, Danen EHJ, Veerkamp JH, et al. Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 1995; 61: 241-248.
17. Moretti S, Martini L, Berti E, Pinzi C, Gianotti B. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 1993; 3: 235-239.
18. Manten-Horst E, Danen EHJ, Smit L, et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995; 64: 182-188.
19. Pals ST, Hogervorst F, Keizer GD, et al. Identification of a widely distributed 90kD glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J Immunol 1989; 143: 851-857.
20. Tax WJM, Willems HW, Reekers PPM, Capel PJA, Koene RAP. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 1983; 304: 445-447.
21. Ksander BR, Rubsamen BE, Olsenk R, Cousius SW, Streilein JW. Studies of tumour-infiltrating lymphocytes from a human choroidal melanoma. Invest Ophthalmol Vis Sci 1991; 32: 3198-3208.
22. De Waard-Siebinga I, Blom D-JR, Grifioen M, et al. Establishment and characterization of a uveal melanoma cell line. Int J Cancer 1995; 62: 155-166.
23. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 1989; 30: 829-834.
24. Danen EHJ, Van Muijen GNP, van de Wiel-van Kemenade E, et al. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and non-metastatic and highly metastatic human melanoma cells. Int J Cancer 1993; 54: 315-321.
25. Ten Berge PJM, Danen EHJ, Van Muijen GNP, Jager M, Ruiter DJ. Integrin expression in uveal melanoma differs from cutaneous melanoma. Invest Ophthalmol Vis Sci 1993; 34: 3635-3640.